[CURRENT TRENDS IN THE PREVENTION, DIAGNOSIS AND TREATMENT OF RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE (REVIEW)]. 2019

E Yakimenko, and L Zakatova, and V Tbilieli, and N Antipova, and S Kolomiets, and N Tikhonchuk, and V Bondar, and V Klochko
Odessa National Medical University, Ukraine.

The purpose of the work is to analyze the evolution of the clinical course, diagnosis, treatment and prevention of acute rheumatic fever (ARF) and chronic rheumatic heart disease (RHD), antibiotic therapy of streptococcal infection, using modern analysis of modern literature and our own observations. Diagnostic criteria for the disease were revised. Improving the capabilities of echocardiography can improve the prognosis of the disease through the early use of treatment and prevention. The level of ORL / RHD correlates with the economic development of countries. Mutation of the etiological factor of rheumatism - ß-HSA, the formation of antibiotic resistance, increased migration, tourist activity in countries with high morbidity due to ß-HSA can lead to new outbreaks of this infection. Prevention ARF/RHD is multistage. Thus, using the experience of healthcare in different countries, new approaches to prevention can improve disease control.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012213 Rheumatic Fever A febrile disease occurring as a delayed sequela of infections with STREPTOCOCCUS PYOGENES. It is characterized by multiple focal inflammatory lesions of the connective tissue structures, such as the heart, blood vessels, and joints (POLYARTHRITIS) and brain, and by the presence of ASCHOFF BODIES in the myocardium and skin. Acute Rheumatic Fever,Arthritis, Rheumatic, Acute,Rheumatism, Articular, Acute,Arthritis, Acute Rheumatic,Inflammatory Rheumatism,Polyarthritis Rheumatica,Rheumatic Arthritis,Rheumatism, Acute Articular,Acute Articular Rheumatism,Acute Articular Rheumatisms,Acute Rheumatic Arthritides,Acute Rheumatic Arthritis,Acute Rheumatic Fevers,Arthritis, Rheumatic,Articular Rheumatism, Acute,Fever, Acute Rheumatic,Fever, Rheumatic,Fevers, Acute Rheumatic,Inflammatory Rheumatisms,Polyarthritis Rheumaticas,Rheumatic Arthritides,Rheumatic Arthritis, Acute,Rheumatic Fever, Acute,Rheumatic Fevers,Rheumatism, Inflammatory
D012214 Rheumatic Heart Disease Cardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM. Bouillaud Disease,Bouillaud's Disease,Bouillauds Disease,Disease, Bouillaud,Disease, Bouillaud's,Disease, Rheumatic Heart,Diseases, Rheumatic Heart,Heart Disease, Rheumatic,Heart Diseases, Rheumatic,Rheumatic Heart Diseases
D013290 Streptococcal Infections Infections with bacteria of the genus STREPTOCOCCUS. Group A Strep Infection,Group A Streptococcal Infection,Group A Streptococcal Infections,Group B Strep Infection,Group B Streptococcal Infection,Group B Streptococcal Infections,Infections, Streptococcal,Infection, Streptococcal,Streptococcal Infection

Related Publications

E Yakimenko, and L Zakatova, and V Tbilieli, and N Antipova, and S Kolomiets, and N Tikhonchuk, and V Bondar, and V Klochko
May 1964, Pediatric clinics of North America,
E Yakimenko, and L Zakatova, and V Tbilieli, and N Antipova, and S Kolomiets, and N Tikhonchuk, and V Bondar, and V Klochko
December 1998, Evidence-based cardiovascular medicine,
E Yakimenko, and L Zakatova, and V Tbilieli, and N Antipova, and S Kolomiets, and N Tikhonchuk, and V Bondar, and V Klochko
December 1962, Bulletin on the rheumatic diseases,
E Yakimenko, and L Zakatova, and V Tbilieli, and N Antipova, and S Kolomiets, and N Tikhonchuk, and V Bondar, and V Klochko
May 1971, Revista medica de Chile,
E Yakimenko, and L Zakatova, and V Tbilieli, and N Antipova, and S Kolomiets, and N Tikhonchuk, and V Bondar, and V Klochko
September 1949, Journal - Michigan State Medical Society,
E Yakimenko, and L Zakatova, and V Tbilieli, and N Antipova, and S Kolomiets, and N Tikhonchuk, and V Bondar, and V Klochko
November 1953, Postgraduate medicine,
E Yakimenko, and L Zakatova, and V Tbilieli, and N Antipova, and S Kolomiets, and N Tikhonchuk, and V Bondar, and V Klochko
August 1947, Canadian journal of public health = Revue canadienne de sante publique,
E Yakimenko, and L Zakatova, and V Tbilieli, and N Antipova, and S Kolomiets, and N Tikhonchuk, and V Bondar, and V Klochko
September 1947, Canadian journal of public health = Revue canadienne de sante publique,
E Yakimenko, and L Zakatova, and V Tbilieli, and N Antipova, and S Kolomiets, and N Tikhonchuk, and V Bondar, and V Klochko
December 1964, Medical times,
E Yakimenko, and L Zakatova, and V Tbilieli, and N Antipova, and S Kolomiets, and N Tikhonchuk, and V Bondar, and V Klochko
December 1993, American heart journal,
Copied contents to your clipboard!